OTCBB:LIXT

Lixte Biotechnology Holdings Stock Insider Trading

Healthcare > Biotechnology

Buy LIXT

*Your capital is at risk

$7.30

-0.180 (-2.41%)

At Close: Jun 23, 2026

Lixte Biotechnology Holdings Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 6.68. In total, the insiders bought 2.69M and sold 500K LIXT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	6.68
● Buy	2.69M shares
● Sell	500K shares
94% Buy Activity Moderate Negative Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 30, 2024 Buy	Options to Purchase Common Stock A-Award	Bernards Rene Director	Director	5 304 Value: $7K
Jul 01, 2024 Buy	Options to Purchase Common Stock	Schellens Johannes Henricus Matthias Chief Medical Officer	Officer	15 000 Value: $35.9K
Jul 01, 2024 Buy	Options to Purchase Common Stock	Schellens Johannes Henricus Matthias Chief Medical Officer	Officer	15 000 Value: $35.9K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Bernards Rene Director	Director	10 000 Value: $23.7K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Bernards Rene Director	Director	4 149 Value: $10K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Bernards Rene Director	Director	4 149 Value: $10K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Bernards Rene Director	Director	10 000 Value: $23.7K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Yen Yun Director	Director	10 000 Value: $23.7K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Yen Yun Director	Director	4 527 Value: $10.7K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Forman Stephen J. Director	Director	10 000 Value: $23.7K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Forman Stephen J. Director	Director	3 018 Value: $7K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Brown Regina Director	Director	10 000 Value: $23.7K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Brown Regina Director	Director	4 904 Value: $11.6K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Brown Regina Director	Director	4 904 Value: $11.6K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Brown Regina Director	Director	10 000 Value: $23.7K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Forman Stephen J. Director	Director	3 018 Value: $7K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Forman Stephen J. Director	Director	10 000 Value: $23.7K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Yen Yun Director	Director	4 527 Value: $10.7K
Jun 30, 2024 Buy	Options to Purchase Common Stock A-Award	Yen Yun Director	Director	10 000 Value: $23.7K
Oct 03, 2023 Buy	Common Stock P-Purchase	Bernards Rene Director	Director	5 527 Value: $13.9K
Oct 03, 2023 Buy	Common Stock P-Purchase	Van Der Baan Bastiaan Jeroen President And CEO	CEO / President	10 000 Value: $28.0K
Oct 02, 2023 Buy	Common Stock P-Purchase	Bernards Rene Director	Director	4 473 Value: $10.2K
Sep 26, 2023 Buy	Options to Purchase Common Stock A-Award	Van Der Baan Bastiaan Jeroen President, CEO & Vice Chairman	CEO / President	250 000 Value: $487.5K
Sep 26, 2023 Buy	Options to Purchase Common Stock A-Award	Van Der Baan Bastiaan Jeroen President, CEO & Vice Chairman	CEO / President	250 000 Value: $487.5K
Sep 26, 2023 Buy	Options to Purchase Common Stock A-Award	Van Der Baan Bastiaan Jeroen President, CEO & Vice Chairman	CEO / President	250 000 Value: $487.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at var...

Read Full Profile Here